Longevity Health HoldingsXAGE -23.30%6 Piotroski F-Score is 4 as of Jun. 30, 2026, which is 33% above its 10-year median of 3.00. GuruFocus rates XAGE with a GF Score™ of 6/100. The stock has 3 warning signs investors should review. Among 1,909 Consumer Packaged Goods companies, Longevity Health Holdings ranks worse than 67.16% on this metric.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Longevity Health Holdings has an F-score of 4 indicating the company's financial situation is typical for a stable company.
The historical rank and industry rank for Longevity Health Holdings's Piotroski F-Score or its related term are showing as below:
XAGE'
s Piotroski F-Score Range Over the Past 10 Years
Min: 2 Med: 3 Max: 5
Current: 4
During the past 5 years, the highest Piotroski F-Score of Longevity Health Holdings was 5. The lowest was 2. And the median was 3.
Longevity Health Holdings (OTCPK:XAGE) Piotroski F-Score Explanation
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
Longevity Health Holdings Piotroski F-Score Related Terms
Longevity Health Holdings Piotroski F-Score Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XAGE vs SNBH, SKVI, PG: Piotroski F-Score Comparison
For the Household & Personal Products subindustry, Longevity Health Holdings's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Longevity Health Holdings Piotroski F-Score vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Longevity Health Holdings's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where Longevity Health Holdings's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Longevity Health Holdings's current Net Income (TTM) was -6.83.
==> Negative ==> Score 0.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Longevity Health Holdings's current Cash Flow from Operations (TTM) was -3.06.
==> Negative ==> Score 0.
Question 3. Change in Return on Assets
Compare this year's return on assets (1) to last year's return on assets.
Longevity Health Holdings's return on assets of this year was -2.04704825. Longevity Health Holdings's return on assets of last year was -1.3920712.
==> Last year is higher ==> Score 0.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
Longevity Health Holdings's gearing of this year was 0.06544138. Longevity Health Holdings's gearing of last year was 0.07824769.
==> This year is lower or equal to last year. ==> Score 1.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
Longevity Health Holdings's current ratio of this year was 0.1512756. Longevity Health Holdings's current ratio of last year was 0.42324595.
==> Last year's current ratio is higher ==> Score 0.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
Longevity Health Holdings's number of shares in issue this year was 1.9. Longevity Health Holdings's number of shares in issue last year was 0.991.
==> There is larger number of shares in issue this year. ==> Score 0.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
Longevity Health Holdings's gross margin of this year was 0.59164345. Longevity Health Holdings's gross margin of last year was 0.56071429.
==> This year's gross margin is higher. ==> Score 1.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
Longevity Health Holdings's asset turnover of this year was 0.5379083. Longevity Health Holdings's asset turnover of last year was 0.09061489.
==> This year's asset turnover is higher. ==> Score 1.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
0
+
0
+
0
+
1
+
1
+
0
+
0
+
1
+
1
=
4
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Longevity Health Holdings has an F-score of 4 indicating the company's financial situation is typical for a stable company.
Longevity Health Holdings (XAGE) has a Piotroski F-Score of 4 as of Jun. 30, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Longevity Health Holdings and its competitors. This is 33% above median its historical median of 3.00. Over the past decade, Longevity Health Holdings' Piotroski F-Score has ranged from 2.00 to 5.00. According to the industry distribution chart, Longevity Health Holdings ranks #1282 out of 1909 companies in the Consumer Packaged Goods industry, placing it in the top 67.2%.
Is Longevity Health Holdings' Piotroski F-Score too high?
Longevity Health Holdings' current Piotroski F-Score of 4 is 33% above median its 10-year median of 3.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 5.00. The Consumer Packaged Goods industry median Piotroski F-Score is 5.00. Longevity Health Holdings' value of 4 is 20% below this industry median. Based on the distribution chart, Longevity Health Holdings ranks #1282 out of 1909 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Longevity Health Holdings has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Longevity Health Holdings' Piotroski F-Score compare to SNBH and SKVI?
According to the Consumer Packaged Goods industry distribution chart, Longevity Health Holdings ranks #1282 out of 1909 companies for Piotroski F-Score. This places Longevity Health Holdings in the lower half of its industry. The industry median Piotroski F-Score is 5.00. Longevity Health Holdings' value of 4 is 20% below this benchmark. Historically, Longevity Health Holdings' own Piotroski F-Score has ranged from 2.00 to 5.00 over the past decade. While the company's 10-year median is 3.00 vs. the industry median of 5.00, Longevity Health Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Consumer Packaged Goods company?
The median Piotroski F-Score among Consumer Packaged Goods companies is 5.00, based on 1,909 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Longevity Health Holdings's current Piotroski F-Score of 4 is 20% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Longevity Health Holdings and its competitors. For the Consumer Packaged Goods industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Longevity Health Holdings's current Piotroski F-Score is 4, which is 33% above median its own 10-year median of 3.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Longevity Health Holdings stock overvalued right now?
Longevity Health Holdings (XAGE) has a current Piotroski F-Score of 4. The current Piotroski F-Score is 4, which is 33% above median its 10-year median of 3.00 and 20% below the Consumer Packaged Goods industry median of 5.00. Longevity Health Holdings' overall GF Score™ is 6/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Longevity Health Holdings (XAGE), the current Piotroski F-Score is 4 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Longevity Health Holdings Inc is a bio-aesthetics company focused on longevity and healthy aging. The company develops cosmetic skincare and haircare products designed to support skin and hair health, tailored to meet the technical requirements of professional care providers as well as retail consumers. Its product pipeline also includes regenerative bone and tissue healing solutions, although further research and development in this area has been paused. The company markets its cosmetic products in the United States through business-to-business, direct-to-consumer, and distributor sales channels.
6GF Score
Get the complete analysis for XAGE
Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XAGE has been successfully added to your 
